Skip to content

Cumberland Pharmaceuticals CPIX Intangible assets — net

Intangible assets — net at other companies

PTH
Pelthos Therapeutics Inc.PTHS
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
BridgeBio Pharma logo
BridgeBio PharmaBBIO
RFL
Rafael Holdings, Inc.RFL
Organon logo
OrganonOGN
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM

Other financials

Income statement

See full
Revenue$9.1M-22.0%
Gross profit$7.2M-30.0%
Operating income-$3.1M-342%
Net income-$3.3M-362%
EPS (diluted)-$0.22-375%

Balance sheet

See full
Cash & equivalents$11.0M-27.1%
Total debt$4.8M-7.1%
Total equity$21.6M-24.5%
Total assets$71.0M+1.5%

Cash flow

See full
Operating cash flow$387.0K-90.1%
CapEx--100%
Free cash flow$387.0K-89.9%

Valuation

See full
Market cap$97.09M+138%
Enterprise value$90.91M+207%
P/S2.3×+1.3×

Profitability

See full
Gross margin82.9%-1.4pp
Operating margin-17.2%-125pp
Net margin-17.6%-103pp
FCF margin3.3%

Returns & leverage

See full
Return on equity-29.4%-86.3pp
Debt / equity0.2×0.0×
Current ratio-0.3×

Where this comes from

Reported directly by Cumberland Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsNet.

The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cumberland Pharmaceuticals's intangible assets — net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cumberland Pharmaceuticals's intangible assets — net?
Cumberland Pharmaceuticals (CPIX) reported intangible assets — net of $12.79M in Q1 2026.
How has Cumberland Pharmaceuticals's intangible assets — net changed year-over-year?
Cumberland Pharmaceuticals's intangible assets — net decreased by 24.7% year-over-year, from $16.99M to $12.79M.
What is the long-term trend for Cumberland Pharmaceuticals's intangible assets — net?
Over 5 years (2020 to 2025), Cumberland Pharmaceuticals's intangible assets — net has grown at a -13.0% compound annual growth rate (CAGR), from $28.12M to $14.03M.